Objective This study objectively characterized the microenvironment of
indolent, chronic wounds by developing a method by which minute quant
ities of cytokines could be extracted from chronic wounds and separate
ly identified. Summary Background Data Recombinant DNA technology and
the ability to clone compounds such as cytokines allow new management
schemes for the treatment of acute and chronic wounds. Before treatmen
t with an exogenous cytokine is started, it would be helpful to know t
he endogenous level of that cytokine in the wound. Although various me
thods of extracting cytokines from acute wounds have been reported, no
techniques have existed to reliably measure endogenous levels of cyto
kines in chronic wounds. Methods Porous, inert hydrophilic dextranomer
beads were tested for their ability to absorb or adsorb protein and c
ytokines in vitro with either albumin or albumin laced with various kn
own amounts of cytokines, and then from chronic human pressure ulcers.
The Bradford protein assay was used to determine protein levels. Enzy
me-linked immunosorbent assay (ELISA) techniques were used to determin
e levels of platelet-derived growth factor (PDGF)-AB, basic fibroblast
growth factor (bFGF), epidermal growth factor (EGF), and transforming
growth factor-Beta (TGF-beta) extracted by the beads. Results Between
88% and 98% of known amounts of albumin could be recovered. Similarly
, more than 90% of the laced cytokines could be recovered. In 20 grade
III/IV pressure ulcers, although protein concentrations were remarkab
ly similar, endogenous levels of cytokine growth factors varied tremen
dously. Platelet-derived growth factor-AB ranged from 49 to 867 pg/mL;
bFGF from 47 to 697 pg/mL; and EGF from nondetectable io 247.5 pg/mL.
TGF-B was not detected in 17 of the 20 pressure ulcers. Conclusions T
his new technique appears useful for measuring endogenous levels of cy
tokines. Levels of cytokines found in these chronic wounds are much lo
wer than those reported from acute wounds. The marked variation found
among the 20 wounds may help to explain the differences reported in re
cent wound healing trials with exogenous cytokines.